
About Narendra Investments
Narendra Investments was a publicly listed company based in Thane (India) founded in 1977. Functions as an investment management firm handling diversified funds and portfolios. It operates on a B2B model. Narendra Investments has completed 2 acquisitions, including Fudkor India and Vegicofoods.com. Its Indian entity Eiko Lifesciences Limited reported revenue of ₹53.73 Cr. The company is recorded as dissolved. Its focus areas include Finance, Investment Management, Asset Management and Diversified Portfolios. Similar companies include UTI Mutual Fund, 360 One and Avendus; 2 of its 3 listed similar companies have raised funding.
Company details
Narendra Investments, based in Thane, focuses on finance, investment management, managing assets, and diversified portfolios. Functions as an investment management firm handling diversified funds and portfolios. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Thane, India
- Stage Public
- SectorsFinancial Services
- Website narendrainvestment.com
- Legal Name Narendra Investments (Delhi) Limited
- Date of Incorporation 07 Jan, 1977
- Jurisdiction Thane, Maharashtra, India
- Market Cap₹74.70 Cr
EIKO · BSE
- Share Price₹49.23
-3.45% today
- Revenue₹52.57 Cr
FY 2025-26 · +39.6% YoY
- EBITDA₹7.32 Cr
Margin 13.9%
- Net Profit₹5.31 Cr
FY 2025-26 · +185.5% YoY
- P/E (TTM)14.2x
P/B 1.0x
- ROE8.5%
ROCE 11.2%
- Debt / Equity0.06
Interest cover 5.7x
- Investments & AcquisitionsFudkor India
& 1 more
Associated legal entities of Narendra Investments
Narendra Investments operates through Eiko Lifesciences Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eiko Lifesciences Limited Listed CIN L65993MH1977PLC258134 | Active | 07 Jan 1977 | Thane, Maharashtra | ₹53.7 Cr | 11 | View details |
Board of directors of Eiko Lifesciences Limited (Narendra Investments)
Eiko Lifesciences Limited is the primary company behind Narendra Investments. The board of Eiko Lifesciences Limited currently have 9 directors; the longest-serving is Bhavesh Dhirajlal Tanna, appointed in 2013. 21 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bhavesh Dhirajlal Tanna DIN 03353445 | Director | 26 Aug 2013 | 13 yrs 2 mo | Eiko Lifesciences Limited |
| Laxmikant Ramprasad Kabra DIN 00061346 | Director | 26 Aug 2013 | 13 yrs 2 mo | Eiko Lifesciences Limited |
| Kajal Dhanpatraj Kothari DIN 07058562 | Director | 09 Sep 2020 | 6 yrs 2 mo | Eiko Lifesciences Limited |
| Umesh Ravindranath More DIN 09044162 | Whole-time director | 12 Nov 2020 | 6 yrs | Eiko Lifesciences Limited |
| Rajkumar Govindas Baheti DIN 05164182 | Director | 10 Feb 2021 | 5 yrs 9 mo | Eiko Lifesciences Limited |
| Jaid Ismail Kojar DIN 06646692 | CFO | 09 Feb 2022 | 4 yrs 9 mo | Eiko Lifesciences Limited |
| Hasti Arjav Doshi DIN 10757758 | Director | 03 Sep 2024 | 2 yrs 2 mo | Eiko Lifesciences Limited |
| Sumukh Prabhakar Vartak DIN 10977198 | Whole-time director | 29 Jul 2025 | 1 yr 3 mo | Eiko Lifesciences Limited |
| Suraj Mahadev Gaikwad DIN 11159369 | Additional Director | 24 Aug 2026 | 2 mo | Eiko Lifesciences Limited |
IPO & Listings of Narendra Investments
Narendra Investments is a publicly listed company on the BSE with ticker symbol EIKO in India, operating in the Chemicals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Dec 2016
- Listed onBSE: 540204
- Listed entityEiko Lifesciences Limited
- Exchange sectorChemicals
Financials of Narendra Investments
Exchange-reported figures of Eiko Lifesciences Limited, the listed company behind Narendra Investments (BSE: EIKO).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 52.57 | 37.66 | 10.40 | 4.27 | 2.36 |
| Revenue growth | +39.6% | - | +143.6% | +80.9% | - |
| EBITDA | 7.32 | 2.76 | (4.50) | (0.68) | 0.37 |
| EBITDA margin | +13.9% | +7.3% | -43.3% | -15.9% | +15.7% |
| Profit before tax | 7.10 | 3.05 | (4.92) | (1.00) | 0.24 |
| Net profit | 5.31 | 1.86 | (1.89) | (0.45) | 0.19 |
| Net profit margin | +10.1% | +4.9% | -18.2% | -10.5% | +8.1% |
| EPS (₹) | 3.71 | 1.68 | (4.99) | 0.00 | 0.51 |
| Balance sheet | |||||
| Total assets | 74.56 | 59.77 | 2.72 | 6.17 | 7.53 |
| Net worth | 68.79 | 56.79 | 2.95 | 4.92 | 5.56 |
| Total debt | 4.73 | 2.76 | 1.61 | 1.37 | 1.74 |
| Cash & bank | 13.61 | 11.78 | 0.02 | 0.11 | 0.80 |
| Net working capital | 33.69 | 27.38 | (4.31) | 1.04 | 2.57 |
| Cash flow | |||||
| Cash from operations | 2.25 | 2.78 | (0.33) | 0.16 | 0.00 |
| Cash from investing | (8.63) | (11.30) | (0.71) | (0.30) | 0.00 |
| Cash from financing | 8.21 | 6.96 | 0.95 | (0.55) | 0.00 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.72 | 16.75 | 18.34 | 11.98 | 11.67 | 10.71 | 11.27 | 7.49 |
| Revenue growth (YoY) | +51.8% | +56.4% | +62.7% | +60.0% | +43.0% | -0.4% | - | - |
| Other income | 0.24 | 0.45 | 0.13 | 0.35 | 0.30 | 0.27 | 0.64 | 0.12 |
| EBITDA | 2.23 | 1.94 | 2.26 | 1.87 | 1.76 | 1.51 | 1.31 | 0.64 |
| EBITDA margin | +12.6% | +11.6% | +12.3% | +15.6% | +15.1% | +14.1% | +11.6% | +8.5% |
| Depreciation | 0.26 | 0.25 | 0.25 | 0.26 | 0.26 | 0.25 | 0.25 | 0.16 |
| Interest | 0.16 | 0.13 | 0.12 | 0.07 | 0.10 | 0.05 | 0.07 | 0.03 |
| Profit before tax | 2.05 | 2.01 | 2.02 | 1.89 | 1.70 | 1.48 | 1.63 | 0.57 |
| Tax | 0.50 | 0.49 | 0.52 | 0.47 | 0.42 | 0.37 | 0.39 | 0.14 |
| Net profit | 1.55 | 1.52 | 1.50 | 1.42 | 1.28 | 1.11 | 1.24 | 0.43 |
| EPS (₹) | 0.78 | 0.76 | 0.86 | 0.88 | 0.78 | 0.66 | 0.80 | 0.32 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 42.13 | 32.49 | 27.93 | 18.32 | 25.41 | 11.99 | 0.00 |
| Revenue growth | +29.7% | +16.3% | +52.5% | -27.9% | +111.9% | - | - |
| EBITDA | 3.37 | 1.71 | 1.62 | 0.96 | 1.32 | 0.52 | (0.17) |
| EBITDA margin | +8.0% | +5.3% | +5.8% | +5.2% | +5.2% | +4.3% | - |
| Profit before tax | 4.72 | 2.32 | 0.99 | 1.02 | 0.95 | 0.83 | 0.13 |
| Net profit | 3.59 | 1.31 | 0.76 | 0.74 | 0.72 | 0.61 | 0.13 |
| Net profit margin | +8.5% | +4.0% | +2.7% | +4.0% | +2.8% | +5.1% | - |
| EPS (₹) | 2.50 | 1.26 | 0.58 | 0.92 | 0.85 | 1.61 | 0.33 |
| Balance sheet | |||||||
| Total assets | 69.17 | 58.18 | 50.68 | 29.48 | 33.26 | 14.35 | 5.74 |
| Net worth | 67.51 | 56.42 | 50.68 | 29.43 | 28.63 | 12.53 | 5.48 |
| Total debt | 1.67 | 1.75 | 0.00 | 0.05 | 4.63 | 1.83 | 0.26 |
| Cash & bank | 13.55 | 11.51 | 13.35 | 0.61 | 0.22 | 4.07 | 0.02 |
| Net working capital | 25.59 | 27.05 | 29.43 | 8.15 | 11.01 | 8.44 | 2.14 |
| Cash flow | |||||||
| Cash from operations | 6.92 | 2.05 | (7.08) | 4.22 | (7.73) | (0.83) | 0.77 |
| Cash from investing | (11.21) | (9.85) | (0.55) | 0.87 | 0.59 | (2.94) | (0.65) |
| Cash from financing | 6.33 | 5.97 | 20.36 | (4.70) | 3.28 | 7.81 | (0.13) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.66 | 14.18 | 15.90 | 9.57 | 9.20 | 7.45 | 7.09 | 6.91 |
| Revenue growth (YoY) | +59.4% | +90.3% | +124.3% | +38.5% | +18.9% | -30.7% | - | - |
| Other income | 0.48 | 0.68 | 0.45 | 0.56 | 0.56 | 0.55 | 0.87 | 0.10 |
| Total expenses | 13.49 | 13.27 | 14.68 | 8.70 | 8.48 | 6.93 | 6.58 | 6.46 |
| EBITDA | 1.17 | 0.91 | 1.22 | 0.87 | 0.72 | 0.52 | 0.51 | 0.45 |
| EBITDA margin | +8.0% | +6.4% | +7.7% | +9.1% | +7.8% | +7.0% | +7.2% | +6.5% |
| Depreciation | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| Interest | 0.07 | 0.04 | 0.04 | 0.04 | 0.07 | 0.02 | 0.04 | 0.02 |
| Profit before tax | 1.43 | 1.40 | 1.48 | 1.24 | 1.06 | 0.90 | 1.19 | 0.38 |
| Tax | 0.32 | 0.34 | 0.37 | 0.29 | 0.25 | 0.22 | 0.30 | 0.10 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.72 | 16.75 | 18.34 | 11.98 | 11.67 | 10.71 | 11.27 | 7.49 |
| Revenue growth (YoY) | +51.8% | +56.4% | +62.7% | +60.0% | +43.0% | -0.4% | - | - |
| Other income | 0.24 | 0.45 | 0.13 | 0.35 | 0.30 | 0.27 | 0.64 | 0.12 |
| EBITDA | 2.23 | 1.94 | 2.26 | 1.87 | 1.76 | 1.51 | 1.31 | 0.64 |
| EBITDA margin | +12.6% | +11.6% | +12.3% | +15.6% | +15.1% | +14.1% | +11.6% | +8.5% |
| Depreciation | 0.26 | 0.25 | 0.25 | 0.26 | 0.26 | 0.25 | 0.25 | 0.16 |
| Interest | 0.16 | 0.13 | 0.12 | 0.07 | 0.10 | 0.05 | 0.07 | 0.03 |
| Profit before tax | 2.05 | 2.01 | 2.02 | 1.89 | 1.70 | 1.48 | 1.63 | 0.57 |
| Tax | 0.50 | 0.49 | 0.52 | 0.47 | 0.42 | 0.37 | 0.39 | 0.14 |
| Net profit | 1.55 | 1.52 | 1.50 | 1.42 | 1.28 | 1.11 | 1.24 | 0.43 |
| EPS (₹) | 0.78 | 0.76 | 0.86 | 0.88 | 0.78 | 0.66 | 0.80 | 0.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Revenue | 52.57 | 37.66 | 10.40 | 4.27 | 2.36 |
| Revenue growth | +39.6% | - | +143.6% | +80.9% | - |
| Other income | 1.16 | 1.20 | 0.01 | 0.04 | 0.04 |
| Total expenses | 45.25 | 34.90 | 14.90 | 4.95 | 1.99 |
| Employee cost | 0.48 | 0.29 | 2.58 | 0.78 | 0.18 |
| EBITDA | 7.32 | 2.76 | (4.50) | (0.68) | 0.37 |
| EBITDA margin | +13.9% | +7.3% | -43.3% | -15.9% | +15.7% |
| Depreciation | 1.02 | 0.74 | 0.19 | 0.17 | 0.08 |
| Interest | 0.36 | 0.17 | 0.24 | 0.19 | 0.09 |
| Profit before tax | 7.10 | 3.05 | (4.92) | (1.00) | 0.24 |
| Tax | 1.79 | 0.75 | (1.32) | (0.21) | 0.05 |
| Net profit | 5.31 | 1.86 | (1.89) | (0.45) | 0.19 |
| Net profit margin | +10.1% | +4.9% | -18.2% | -10.5% | +8.1% |
| EPS (₹) | 3.71 | 1.68 | (4.99) | 0.00 | 0.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 14.35 | 13.76 | 3.82 | 3.82 | 3.82 |
| Reserves & surplus | 50.38 | 43.03 | (0.87) | 1.10 | 1.74 |
| Shareholders' funds (net worth) | 68.79 | 56.79 | 2.95 | 4.92 | 5.56 |
| Minority interest | 1.05 | 0.22 | (1.83) | (0.12) | 0.22 |
| Secured loans | 4.73 | 2.76 | 1.61 | 1.37 | 1.74 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 4.73 | 2.76 | 1.61 | 1.37 | 1.74 |
| Total liabilities | 74.56 | 59.77 | 2.72 | 6.17 | 7.53 |
| Assets | |||||
| Gross block | 25.95 | 25.95 | 1.75 | 1.71 | 2.27 |
| Net block | 22.10 | 23.11 | 1.75 | 1.71 | 1.69 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 15.29 | 7.15 | 0.10 | 1.72 | 3.17 |
| Inventories | 3.97 | 5.77 | 3.21 | 2.31 | 3.10 |
| Sundry debtors | 20.22 | 10.79 | 1.18 | 0.86 | 1.46 |
| Cash & bank balances | 13.61 | 11.78 | 0.02 | 0.11 | 0.80 |
| Loans & advances | 9.60 | 4.54 | 0.62 | 0.89 | 0.61 |
| Total current assets | 47.40 | 32.88 | 5.03 | 4.17 | 5.97 |
| Total current liabilities | 13.71 | 5.50 | 9.34 | 3.13 | 3.40 |
| Net working capital | 33.69 | 27.38 | (4.31) | 1.04 | 2.57 |
| Total assets | 74.56 | 59.77 | 2.72 | 6.17 | 7.53 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Opening cash | 11.78 | 13.35 | 0.11 | 0.80 | 0.00 |
| Net cash from operating activities | 2.25 | 2.78 | (0.33) | 0.16 | 0.00 |
| Net cash from investing activities | (8.63) | (11.30) | (0.71) | (0.30) | 0.00 |
| Net cash from financing activities | 8.21 | 6.96 | 0.95 | (0.55) | 0.00 |
| Net change in cash | 1.83 | (1.57) | (0.09) | (0.69) | 0.00 |
| Closing cash | 13.61 | 11.78 | 0.02 | 0.11 | 0.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +39.6% | - | +143.6% | +80.9% | - |
| EBITDA growth | +165.2% | - | -561.8% | -283.8% | - |
| PBT growth | +132.8% | +9998.0% | -392.0% | - | +9997.0% |
| Net income growth | +185.5% | - | -320.0% | -336.8% | - |
| Revenue CAGR (3Y) | +130.9% | +151.8% | - | - | - |
| EBITDA CAGR (3Y) | - | +95.4% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +10.1% | +6.1% | -34.6% | -18.5% | +8.1% |
| Return on capital employed | +11.2% | +4.8% | 0.0% | 0.0% | +4.7% |
| Return on net worth | +8.5% | +3.3% | 0.0% | 0.0% | +3.6% |
| Debt / equity | 0.06 | 0.05 | 0.38 | 0.30 | 0.31 |
| Long-term debt / equity | 0.04 | 0.04 | 0.26 | 0.09 | 0.09 |
| Interest cover | 5.71 | 8.42 | -5.12 | -22.35 | 31.03 |
| Efficiency & per share | |||||
| Fixed asset turnover | 2.03 | 1.45 | 6.01 | 2.15 | 1.04 |
| Inventory turnover | 10.79 | 6.53 | 3.77 | 1.58 | 0.76 |
| Debtors turnover | 3.39 | 3.49 | 10.20 | 3.68 | 1.62 |
| EPS (₹) | 3.71 | 1.68 | (4.99) | 0.00 | 0.51 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 45.12 | 41.26 | 7.71 | 12.89 | 14.56 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.66 | 14.18 | 15.90 | 9.57 | 9.20 | 7.45 | 7.09 | 6.91 |
| Revenue growth (YoY) | +59.4% | +90.3% | +124.3% | +38.5% | +18.9% | -30.7% | - | - |
| Other income | 0.48 | 0.68 | 0.45 | 0.56 | 0.56 | 0.55 | 0.87 | 0.10 |
| Total expenses | 13.49 | 13.27 | 14.68 | 8.70 | 8.48 | 6.93 | 6.58 | 6.46 |
| EBITDA | 1.17 | 0.91 | 1.22 | 0.87 | 0.72 | 0.52 | 0.51 | 0.45 |
| EBITDA margin | +8.0% | +6.4% | +7.7% | +9.1% | +7.8% | +7.0% | +7.2% | +6.5% |
| Depreciation | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| Interest | 0.07 | 0.04 | 0.04 | 0.04 | 0.07 | 0.02 | 0.04 | 0.02 |
| Profit before tax | 1.43 | 1.40 | 1.48 | 1.24 | 1.06 | 0.90 | 1.19 | 0.38 |
| Tax | 0.32 | 0.34 | 0.37 | 0.29 | 0.25 | 0.22 | 0.30 | 0.10 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 42.13 | 32.49 | 27.93 | 18.32 | 25.41 | 11.99 | 0.00 |
| Revenue growth | +29.7% | +16.3% | +52.5% | -27.9% | +111.9% | - | - |
| Other income | 2.13 | 1.37 | 0.18 | 0.85 | 0.67 | 0.46 | 0.43 |
| Total expenses | 38.76 | 30.78 | 26.31 | 17.36 | 24.09 | 11.47 | 0.17 |
| Employee cost | 0.23 | 0.22 | 0.16 | 0.23 | 0.23 | 0.12 | 0.07 |
| EBITDA | 3.37 | 1.71 | 1.62 | 0.96 | 1.32 | 0.52 | (0.17) |
| EBITDA margin | +8.0% | +5.3% | +5.8% | +5.2% | +5.2% | +4.3% | - |
| Depreciation | 0.59 | 0.63 | 0.66 | 0.63 | 0.56 | 0.06 | 0.06 |
| Interest | 0.19 | 0.13 | 0.15 | 0.16 | 0.48 | 0.09 | 0.07 |
| Profit before tax | 4.72 | 2.32 | 0.99 | 1.02 | 0.95 | 0.83 | 0.13 |
| Tax | 1.13 | 0.57 | 0.23 | 0.26 | 0.23 | 0.22 | 0.00 |
| Net profit | 3.59 | 1.31 | 0.76 | 0.74 | 0.72 | 0.61 | 0.13 |
| Net profit margin | +8.5% | +4.0% | +2.7% | +4.0% | +2.8% | +5.1% | - |
| EPS (₹) | 2.50 | 1.26 | 0.58 | 0.92 | 0.85 | 1.61 | 0.33 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 14.35 | 13.76 | 12.87 | 8.32 | 8.32 | 3.82 | 3.82 |
| Reserves & surplus | 49.10 | 42.66 | 37.81 | 21.11 | 20.31 | 2.37 | 1.66 |
| Shareholders' funds (net worth) | 67.51 | 56.42 | 50.68 | 29.43 | 28.63 | 12.53 | 5.48 |
| Secured loans | 1.67 | 1.75 | 0.00 | 0.05 | 3.08 | 0.20 | 0.26 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 1.55 | 1.63 | 0.00 |
| Total debt | 1.67 | 1.75 | 0.00 | 0.05 | 4.63 | 1.83 | 0.26 |
| Total liabilities | 69.17 | 58.18 | 50.68 | 29.48 | 33.26 | 14.35 | 5.74 |
| Assets | |||||||
| Gross block | 16.99 | 16.99 | 15.69 | 15.34 | 15.12 | 0.52 | 0.52 |
| Net block | 13.67 | 14.26 | 13.56 | 13.88 | 14.29 | 0.25 | 0.31 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 15.15 | 7.07 | 4.02 | 0.05 | 0.20 | 0.22 | 0.50 |
| Inventories | 3.97 | 4.02 | 3.39 | 0.91 | 5.46 | 0.06 | 0.00 |
| Sundry debtors | 18.89 | 10.14 | 13.13 | 7.11 | 4.56 | 3.41 | 0.00 |
| Cash & bank balances | 13.55 | 11.51 | 13.35 | 0.61 | 0.22 | 4.07 | 0.02 |
| Loans & advances | 2.04 | 2.90 | 1.06 | 0.67 | 2.20 | 3.16 | 2.14 |
| Total current assets | 38.45 | 28.57 | 30.93 | 9.30 | 12.44 | 10.70 | 2.16 |
| Total current liabilities | 12.86 | 1.52 | 1.50 | 1.15 | 1.43 | 2.26 | 0.02 |
| Net working capital | 25.59 | 27.05 | 29.43 | 8.15 | 11.01 | 8.44 | 2.14 |
| Total assets | 69.17 | 58.18 | 50.68 | 29.48 | 33.26 | 14.35 | 5.74 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 11.51 | 13.35 | 0.61 | 0.22 | 4.07 | 0.02 | 0.03 |
| Net cash from operating activities | 6.92 | 2.05 | (7.08) | 4.22 | (7.73) | (0.83) | 0.77 |
| Net cash from investing activities | (11.21) | (9.85) | (0.55) | 0.87 | 0.59 | (2.94) | (0.65) |
| Net cash from financing activities | 6.33 | 5.97 | 20.36 | (4.70) | 3.28 | 7.81 | (0.13) |
| Net change in cash | 2.04 | (1.83) | 12.73 | 0.40 | (3.85) | 4.05 | (0.01) |
| Closing cash | 13.55 | 11.51 | 13.35 | 0.61 | 0.22 | 4.07 | 0.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +29.7% | +16.3% | +52.5% | -27.9% | +111.9% | - | - |
| EBITDA growth | +97.1% | +5.6% | +68.8% | -27.3% | +153.9% | +405.9% | - |
| PBT growth | +103.5% | +134.3% | -2.9% | +7.4% | +14.5% | +538.5% | +18.2% |
| Net income growth | +174.1% | +72.4% | +2.7% | +2.8% | +18.0% | +369.2% | - |
| Revenue CAGR (3Y) | +32.0% | +8.5% | +32.6% | - | +302.4% | +186.5% | -100.0% |
| EBITDA CAGR (3Y) | +52.0% | +9.0% | +46.1% | - | +87.6% | +16.4% | - |
| Profitability & leverage | |||||||
| Net income margin | +8.5% | +5.4% | +2.7% | +4.2% | +2.8% | +5.1% | - |
| Return on capital employed | +7.7% | +3.8% | +2.8% | +3.8% | +6.0% | +9.2% | +3.5% |
| Return on net worth | +5.8% | +2.4% | +1.9% | +2.7% | +3.5% | +6.8% | +2.4% |
| Debt / equity | 0.03 | 0.02 | 0.00 | 0.08 | 0.16 | 0.12 | 0.05 |
| Long-term debt / equity | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 |
| Interest cover | 6.83 | 12.04 | 15.63 | 48.48 | 63.16 | 19.57 | -30.43 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.48 | 1.99 | 1.80 | 1.20 | 3.25 | 23.06 | 0.00 |
| Inventory turnover | 10.55 | 8.77 | 12.99 | 5.75 | 9.21 | 399.67 | 0.00 |
| Debtors turnover | 2.90 | 2.79 | 2.76 | 3.14 | 6.38 | 7.03 | 0.00 |
| EPS (₹) | 2.50 | 1.26 | 0.58 | 0.92 | 0.85 | 1.61 | 0.33 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 44.22 | 41.00 | 39.37 | 35.38 | 34.43 | 16.19 | 14.35 |
Investments & Acquisitions by Narendra Investments
Narendra Investments has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Fudkor India and Vegicofoods.com.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Spices are branded and distributed by Fudkor India from Mumbai. | fudkorindia.com | Mumbai, India | 2004 | Apr 2018 | •••• | |
Brand of vegetables | vegicofoods.com | 0 | Apr 2018 | •••• |
Complete acquisition details for Narendra Investments
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Narendra Investments
4 dated milestones of Narendra Investments across 41 years, from founding to its latest funding, stage changes and deals.
- Founded Narendra Investments is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Vegicofoods.com.
- Acquisition Acquires Fudkor India.
Similar companies to Narendra Investments
Narendra Investments has 3 listed similar companies in our database, 2 of them funded. They include UTI Mutual Fund, 360 One and Avendus.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| utimf.com | 2001 | Mumbai, India | $142.4M | 1,468 | Mutual funds, portfolio management, and retirement planning services are offered. | |
| 360.one | 2008 | Mumbai, India | 65 | Asset and wealth management software is provided for businesses. | ||
| avendus.com | 1999 | Mumbai, India | $178.11M | 215 | Corporate advisory and investment services are provided to clients. |
Detailed similar companies of Narendra Investments
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Asset Management
3 companies that operate in the same segment as Narendra Investments (Asset Management) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provides mutual funds management and financial advisory services. | 1987 | Mumbai, Maharashtra, India | ||||
Mutual funds, portfolio management, and retirement planning services are offered. | 2001 | Mumbai, Maharashtra, India | USD 142.4 M | USD 180.76 M | 1,840 | |
Online platform for stock trading, mutual funds, and investment tools. | 1994 | Mumbai, Maharashtra, India |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Narendra Investments
Complete news archive for Narendra Investments
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narendra Investments
Narendra Investments was founded in 1977.
Narendra Investments is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
The primary company behind Narendra Investments, Eiko Lifesciences Limited, reported revenue of ₹53.73 Cr for FY 2026, up 40% year on year.
Narendra Investments, based in Thane, focuses on finance, investment management, managing assets, and diversified portfolios. Functions as an investment management firm handling diversified funds and portfolios. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Narendra Investments's top competitors include UTI Mutual Fund, Avendus and 360 One.
Yes, Narendra Investments is publicly traded on BSE under the ticker symbol EIKO.
Narendra Investments has made 2 acquisitions, including Fudkor India, and Vegicofoods.com.
Narendra Investments operates through Eiko Lifesciences Limited.
The legal entities of Narendra Investments currently have 10 directors, including Bhavesh Dhirajlal Tanna, Jaid Ismail Kojar, Umesh Ravindranath More and others.
